They are made by Novo Nordisk, and its market value “has risen by more than a third so far this year to about $419 billion, bigger than the country’s gross domestic product of about $406 billion,” according to The Wall Street Journal. “Because the pharmaceutical industry’s exports have grown so much, it’s creating a big influx of currency into the Danish economy,” Danske Bank director Jens Naervig Pedersen tells WSJ.
Wegovy is approved for people with obesity, or genetics that lead to obesity. It’s also not a general purpose weight loss product, it’s for people who can’t control their weight without medication.
Wegovy (same drug, same company, just different branding to Ozempic) is approved for weight control in non-diabetics: https://ec.europa.eu/health/documents/community-register/html/h1608.htm
Yes, https://en.wikipedia.org/wiki/Semaglutide
Wegovy is approved for people with obesity, or genetics that lead to obesity. It’s also not a general purpose weight loss product, it’s for people who can’t control their weight without medication.